November 25, 2014 6:25 PM ET


Company Overview of Aché Laboratórios Farmacêuticos S.A.

Company Overview

Aché Laboratórios Farmacêuticos S.A. produces and sells pharmaceutical products for healthcare professionals and consumers in Brazil. It offers a portfolio of prescription, non-prescription, and generic drugs, as well as skin care products, nutraceuticals, and probiotics. The company also exports its products to Mexico. Aché Laboratórios Farmacêuticos S.A. was founded in 1966 and is headquartered in Guarulhos, Brazil.

Rodovia Presidente Dutra, Km 222.2

Harbor Church

Guarulhos, SP 07034-904


Founded in 1966


55 11 2608 6000


55 11 2608 6178

Key Executives for Aché Laboratórios Farmacêuticos S.A.

Chief Operating Officer
Compensation as of Fiscal Year 2014.

Aché Laboratórios Farmacêuticos S.A. Key Developments

BioGaia Signs Long-Term Agreement with Aché

BioGaia has signed a long-term agreement with Aché, for the exclusive rights to sell BioGaia's probiotic drops and tablets in Brazil. The products will be co-branded and launch is planned to mid 2014.

Suitors Reportedly Plan Second-Round Bids For Aché Laboratórios

Pfizer Inc., Novartis AG and Abbott Laboratories are in race to acquire Aché Laboratórios Farmacêuticos S.A., Reuters reported citing people close to the matter. The potential transaction is valued more than $5 billion. The suitors are weighing second-round bids, which are due in second half of April, the report stated. Aché Laboratórios is controlled by Dellape Baptista, Siaulys and Depieri families. The sale is facing hurdles due to disputes among the stakeholders and also forced GlaxoSmithKline plc to walk out of the bidding process last month. The Baptista and Siaulys families still intend to sell their stake and have retained Lazard for the process. The Depieri family intends to hold on to its stake and is looking for local partners to acquire the Baptista and Siaulys families’ stakes. The Depieri family is known to have retained BTG Pactual to develop a new business plan for the company.

GSK Seeks To Acquire Aché Laboratórios

GlaxoSmithKline plc (GSK) announced that it is considering acquisitions in Brazil, especially Aché Laboratórios Farmacêuticos S.A. According to Handelsblatt Wirtschafts, GSK is ready to pay between $3 billion and $4 billion for the potential acquisition of Ache.

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Aché Laboratórios Farmacêuticos S.A., please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at